Matrix Capital Management Company, LP
CIK
1410830
Location
Portsmouth, NH
Portfolio Value
Micro
$46,314,000
Diversification
Highly concentrated
Filing Date
Global Rank
#8,515
/ 8,794
▼ 4
· as of Mar 2026
Top Industry
Biotechnology
100.0%
Period ended 6 months ago
Filed May 14, 2026 · 4mo
25 quarters · since Mar 2020
Portfolio Concentration
1 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
100.0%
+34.5 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated+4,520
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $46,314,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | 480,000 | $19,886,400 | |
| No positions match the current search. | ||||
1 tracked positions ·
$46,314,000 total
· filing declares
1 positions · $46,314,000
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AURA |
Aura Biosciences, Inc.
Healthcare
|
Held | 6,922,870 | $46,314,000 | 100.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.